aTyr Pharma(LIFE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LIFE aTyr Pharma

Trading 12-11 14:32:47 EST

1.90

+0.00

0.00%

High1.90	Low1.90	Vol0.00
Open1.90	D1 Closing1.90	Amplitude0.00%
Mkt Cap131.12M	Tradable Cap127.63M	Total Shares69.01M
T/O506.87K	T/O Rate0.00%	Tradable Shares67.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LIFE","market":"US","secType":"STK","nameCN":"aTyr Pharma","latestPrice":1.9,"timestamp":1717531200000,"preClose":1.9,"halted":8,"volume":0,"delay":0,"floatShares":67173358,"shares":69010940,"eps":-0.904057,"marketStatus":"Trading","change":0,"latestTime":"12-11 14:32:47 EST","open":1.9,"high":1.9,"low":1.9,"amount":506865.2986371,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.904057,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"symbolChange":{"newSymbol":"ATYR","executeDate":"2024-06-05"},"adr":0,"adrRate":0,"listingDate":1430971200000,"exchange":"NASDAQ","adjPreClose":1.9,"volumeRatio":0},"requestUrl":"/m/hq/s/LIFE","defaultTab":"news","newsList":[{"id":"2441172786","title":"News On aTyr Pharma Inc. (LIFE) Now Under ATYR","url":"https://stock-news.laohu8.com/highlight/detail?id=2441172786","media":"DowjonesLive","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441172786?lang=en_us&edition=fundamental","pubTime":"2024-06-06 05:08","pubTimestamp":1717621680,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"dowjones_live","symbols":["BK4139","LIFE","BK4563","ATYR"],"gpt_icon":0},{"id":"2440462552","title":"aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”","url":"https://stock-news.laohu8.com/highlight/detail?id=2440462552","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2440462552?lang=en_us&edition=fundamental","pubTime":"2024-06-03 20:00","pubTimestamp":1717416000,"startTime":"0","endTime":"0","summary":"Ticker symbol change to take effect on Wednesday, June 5, 2024SAN DIEGO, June  03, 2024  (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/03/2892167/0/en/aTyr-Pharma-Announces-Nasdaq-Stock-Ticker-Symbol-Change-from-LIFE-to-ATYR.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIFE","NDAQ","LU2210150020.SGD",".IXIC","BK4563","BK4588","LU2210149790.SGD","BK4585","BK4139","LU2095319765.USD","BK4112"],"gpt_icon":0},{"id":"2438060142","title":"aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2438060142","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2438060142?lang=en_us&edition=fundamental","pubTime":"2024-05-25 04:00","pubTimestamp":1716580800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, May  24, 2024  (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-cl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/24/2888158/0/en/aTyr-Pharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LIFE","BK4139","BK4112","LU2210149790.SGD","LU2095319765.USD","BK4563","BK4588","BK4585","NDAQ",".IXIC"],"gpt_icon":0},{"id":"2437328794","title":"SWISS LIFE HOLDING AG :Swiss Life Increases Fee Income By 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2437328794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2437328794?lang=en_us&edition=fundamental","pubTime":"2024-05-22 13:03","pubTimestamp":1716354210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_live","symbols":["AG","LIFE","BK4210","BK4139","BK4563"],"gpt_icon":0},{"id":"2435582651","title":"SWISS LIFE HOLDING AG :Swiss Life Shareholders Approve All R","url":"https://stock-news.laohu8.com/highlight/detail?id=2435582651","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435582651?lang=en_us&edition=fundamental","pubTime":"2024-05-15 23:02","pubTimestamp":1715785340,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_live","symbols":["BK4139","AG","LIFE","BK4210","BK4563"],"gpt_icon":0},{"id":"2435635691","title":"aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2435635691","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435635691?lang=en_us&edition=fundamental","pubTime":"2024-05-15 11:00","pubTimestamp":1715742000,"startTime":"0","endTime":"0","summary":"Findings further demonstrate that NRP2 is an important new immune target in ILD and that efzofitimod modulates myeloid cells to confer anti-inflammatory benefitSAN DIEGO, May  15, 2024  (GLOBE NEWSWIR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/15/2882256/0/en/aTyr-Pharma-to-Present-Poster-Describing-Efzofitimod-s-Mechanism-of-Action-at-the-American-Thoracic-Society-2024-International-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIFE","BK4107","BK4117","ATS","BK4139","AFG","BK4563","BK4161"],"gpt_icon":0},{"id":"2435551876","title":"aTyr Pharma Inc :Atyr Pharma Announces Second Positive Dsmb","url":"https://stock-news.laohu8.com/highlight/detail?id=2435551876","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435551876?lang=en_us&edition=fundamental","pubTime":"2024-05-14 20:43","pubTimestamp":1715690637,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_live","symbols":["LIFE","BK4563","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atyrpharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.022427},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.026924},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.036889},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.052458},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.096577},{"month":6,"riseRate":0.6,"avgChangeRate":-0.014529},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.024172},{"month":8,"riseRate":0.111111,"avgChangeRate":-0.082422},{"month":9,"riseRate":0.555556,"avgChangeRate":0.120154},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.07207},{"month":11,"riseRate":0.555556,"avgChangeRate":0.026072},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.077972}],"exchange":"NASDAQ","name":"aTyr Pharma","nameEN":"aTyr Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"aTyr Pharma(LIFE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest aTyr Pharma(LIFE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"aTyr Pharma,LIFE,aTyr Pharma股票,aTyr Pharma股票老虎,aTyr Pharma股票老虎国际,aTyr Pharma行情,aTyr Pharma股票行情,aTyr Pharma股价,aTyr Pharma股市,aTyr Pharma股票价格,aTyr Pharma股票交易,aTyr Pharma股票购买,aTyr Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"aTyr Pharma(LIFE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest aTyr Pharma(LIFE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}